science

An analysis of how global futurist thinking and strategic foresight are influencing international business, policy, and governance, and why leaders need to adopt long-term perspectives.

Medical technology enters a period of accelerated change as China's procurement reforms, outpatient migration, supply chain pressures, GLP-1 therapies, and platform-based competition redefine global healthcare markets.

An analysis of five key medtech trends in 2026, from China's volume-based procurement to GLP-1 therapies and platform-based competition, and their international economic and strategic consequences.

An analysis of five structural forces transforming the medtech industry: China's VBP expansion, outpatient migration, supply chain reconfiguration, GLP-1 drug impact, and platform-based competition.

An analysis of five key medtech trends driving structural change in global healthcare markets, from China's volume-based procurement to platform competition.

A new report from Boston Consulting Group and HealthKois reveals that while India’s life sciences sector has achieved notable milestones in innovation, structural gaps in funding, clinical execution, and supply chains hinder its ability to scale. The findings carry significant implications for global pharmaceutical supply chains, investment flows, and the future of affordable therapeutics.